期刊文献+

消费者重塑医院 美国医院补充与替代医学的发展历程 被引量:1

Are customers reshaping hospitals?
下载PDF
导出
摘要 All types of acute care hospitals across the U.S.are becoming increasingly involved in offering CAM services.Hospitals appear to be responding to consumer demand,CAM specific market forces,and their organizational missions but not to regulatory mandate.In placing and structuring CAM services within the hospital organizational structure,hospitals may face a challenge in maintaining the attractive features of the services.Ultimately,adding CAM services to hospitals could bring the best of both worlds to patients. All types of acute care hospitals across the U.S.are becoming increasingly involved in offering CAM services.Hospitals appear to be responding to consumer demand,CAM specific market forces,and their organizational missions but not to regulatory mandate.In placing and structuring CAM services within the hospital organizational structure,hospitals may face a challenge in maintaining the attractive features of the services.Ultimately,adding CAM services to hospitals could bring the best of both worlds to patients.
作者 何倩
出处 《中国医院院长》 2006年第20期62-64,共3页 China Hospital CEO
  • 相关文献

同被引文献5

  • 1Richard L Nahin. Use of the best case series to evaluate complementary and alternative therapies for cancer: a systematic review[J]. Journal of the National Cancer Institute, 2004,29(6): 552-562.
  • 2Ellen Stovall, Dr Jeffrey D White. Alternative Therapies Getting Notice Through Best Case Series Program Journal of the National Cancer Institute[J]. Journal of the National Cancer Institute, 2000,27(19): 1558-1560.
  • 3Banerji P, Campbell DR. Cancer patients treated with the Banerji protocols utilizing homoeopathic medicine: A Best Case Series Program of the National Cancer Institute USA[J]. Oncol Rep, 2008,20(1): 69-74.
  • 4Jacobson JS, Grann VR, Gnatt MA, et al. Cancer outcomes at the Hufeland (Complementary/Alternative medicine) klinik: a best-case series review[J]. Integr Cancer Ther, 2005, 4(2): 156-167.
  • 5Carolyn M, Clancy MD. Best-case series for the use of immunoaugmentation therapy and naltrexone cancer[J]. Evidence Report/technology 179-183. for the treatment of Assessment, 2003,78(2).

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部